You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mylotarg

Showing 26 - 50 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukaemia Trial in Worldwide (Gemtuzumab ozogamicin, Liposomal daunorubicin, Mitoxantrone)

Recruiting
  • Acute Myeloid Leukaemia
  • Gemtuzumab ozogamicin
  • +6 more
  • Adelaide, Australia
  • +67 more
Sep 30, 2021

Leukemia Trial in Houston (Mylotarg)

Terminated
  • Leukemia
  • Mylotarg
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 30, 2018

Acute Myeloid Leukemia Trial in La Jolla, Stanford, Atlanta (5-Azacitidine, Gemtuzumab ozogamicin)

Completed
Has Results
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +2 more
Jan 31, 2019

Acute Myeloid Leukaemia, Myelodysplastic Syndrome Trial in Denmark, United Kingdom (Arm A Mylotarg plus DA Versus CPX-351, Arm B

Unknown status
  • Acute Myeloid Leukaemia
  • Myelodysplastic Syndrome
  • Arm A Mylotarg plus DA Versus CPX-351
  • +5 more
  • Aalborg, Denmark
  • +86 more
Jan 22, 2020

Acute Myeloid Leukemia (AML) Trial in France

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
    • Amiens, France
    • +28 more
    Jul 21, 2021

    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

    Completed
    Has Results
    • Adult Acute Megakaryoblastic Leukemia (M7)
    • +13 more
    • Stanford, California
    • +3 more
    May 2, 2019

    Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia
    • +13 more
    • Burbank, California
    • +176 more
    Mar 25, 2022

    Leukemia Trial in Worldwide (asparaginase, cytarabine, daunorubicin HCl)

    Completed
    Has Results
    • Leukemia
    • Birmingham, Alabama
    • +197 more
    Mar 22, 2021

    CD33 Positive Acute Myelogenous Leukemia Trial in United States (Antibody Drug Conjugate Chemotherapeutic)

    No longer available
    • CD33 Positive Acute Myelogenous Leukemia
    • Antibody Drug Conjugate Chemotherapeutic
    • Birmingham, Alabama
    • +141 more
    Aug 17, 2019

    Leukemia Trial in Israel, United States (biological, drug, procedure)

    Completed
    Has Results
    • Leukemia
    • sargramostim
    • +7 more
    • Birmingham, Alabama
    • +98 more
    Oct 23, 2020

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

    Withdrawn
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +7 more
    • gemtuzumab ozogamicin
    • laboratory biomarker analysis
    • (no location specified)
    Jun 29, 2018

    Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +13 more
    • Birmingham, Alabama
    • +187 more
    Apr 28, 2022

    Relapsed/Refractory Acute Myeloid Leukemia Included inPatient

    Unknown status
    • Leukemia, Myeloid, Acute
    • Gemtuzumab Ozogamicin (GO)
    • Amiens, France
    • +10 more
    Jan 23, 2018

    Acute Myeloid Leukemia Trial in France (Gemtuzumab ozogamicin (GO))

    Unknown status
    • Acute Myeloid Leukemia
    • Gemtuzumab ozogamicin (GO)
    • Amiens, France
    • +20 more
    Jul 24, 2018

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

    Approved for marketing
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +9 more
    • gemtuzumab ozogamicin
    • laboratory biomarker analysis
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Feb 28, 2018

    Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

    Recruiting
    • Infusion Reaction
    • Monoclonal Antibody
    • Montelukast 10 Mg Oral Tablet
    • Clovis, California
      Community Cancer Institute
    Nov 8, 2021

    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

    Terminated
    Has Results
    • Adult Acute Megakaryoblastic Leukemia (M7)
    • +14 more
    • gemtuzumab ozogamicin
    • +2 more
    • Stanford, California
    • +3 more
    May 30, 2017

    Acute Myeloid Leukemia Trial in France (gemtuzumab ozogamycin)

    Completed
    • Acute Myeloid Leukemia
    • gemtuzumab ozogamycin
    • Aix, France
    • +28 more
    Jan 26, 2017

    Acute Myeloid Leukemia Trial in Aarhus, Copenhagen (Gemtuzumab ozogamicin)

    Completed
    • Acute Myeloid Leukemia
    • Gemtuzumab ozogamicin
    • Aarhus, Denmark
    • +1 more
    May 12, 2016

    DNA Samples From Younger Newly Diagnosed Acute Myeloid Leukemia

    Completed
    • Leukemia
    • DNA analysis
    • +3 more
    • (no location specified)
    May 17, 2016

    Acute Myeloid Leukemia Trial in Pittsburgh (Gemtuzumab ozogamicin, Mitoxantrone, Etoposide)

    Terminated
    • Acute Myeloid Leukemia
    • Gemtuzumab ozogamicin
    • +2 more
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Cancer Institute / Hillman Cancer Cente
    Jan 14, 2016

    Leukemia, MDS Trial in United Kingdom (cytarabine, daunorubicin HCl, gemtuzumab ozogamicin)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • Basingstoke, England, United Kingdom
    • +5 more
    Sep 19, 2016

    Leukemia Trial in Puerto Rico, United States (ara-C, gemtuzumab ozogamicin)

    Completed
    • Leukemia
    • Anniston, Alabama
    • +77 more
    Jul 12, 2016

    Leukemia Trial in Chapel Hill (clofarabine, gemtuzumab ozogamicin)

    Terminated
    • Leukemia
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Oct 7, 2015

    Leukemia, MDS Trial in Cleveland (arsenic trioxide, gemtuzumab ozogamicin)

    Completed
    Has Results
    • Leukemia
    • Myelodysplastic Syndromes
    • arsenic trioxide
    • gemtuzumab ozogamicin
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Center
    Jul 6, 2015